Interoperable Layer-1 blockchain Injective has secured a major institutional partnership, announcing on Thursday that Deutsche Telekom’s subsidiary MMS is now an official validator on its network. The move marks a significant milestone in Injective’s expansion into enterprise-grade blockchain infrastructure, reinforcing security, decentralization, and institutional adoption of Web3 technologies.
According to the press release shared with Cryptonews, Deutsche Telekom MMS will play a crucial role in securing Injective’s blockchain network by validating transactions and maintaining network integrity. As a validator, the telecommunications giant will help ensure that Injective’s ecosystem remains secure, scalable, and transparent, catering to an increasing number of financial applications such as digital asset trading, tokenization, lending, and decentralized payments.
Injective’s CEO, Eric Chen, expressed enthusiasm about the collaboration, emphasizing that this partnership is a key step in bridging traditional finance and blockchain technology. He highlighted that working with one of the world’s largest telecommunications providers underscores the growing institutional confidence in decentralized finance (DeFi) and blockchain-based financial services.
“This partnership demonstrates that Web3 is no longer a niche industry but is rapidly integrating into mainstream financial and technological infrastructure. A decentralized blockchain provides unmatched reliability and security, which is critical when handling financial transactions,” Chen stated.
Deutsche Telekom MMS’s Head of Digital Trust and Web3 Infrastructure, Oliver Nyderle, echoed these sentiments, stressing that the company’s involvement in blockchain validation aligns with its long-term strategy of fostering trust, security, and decentralization.
“This partnership reflects our commitment to merging cutting-edge technology with institutional-grade security, ensuring that decentralized networks can scale effectively while maintaining the highest levels of trust,” Nyderle said.
This partnership comes on the heels of Injective’s recent launch of an on-chain index via its decentralized exchange, Helix, in early February. The initiative aims to tokenize traditional financial assets, enabling their frictionless trading, settlement, and ownership transfer directly on-chain.
Injective has positioned itself as a leading Layer-1 blockchain tailored for decentralized financial applications, offering developers and users a full suite of blockchain-based trading and financial tools. The platform has received backing from major investors, including Binance, Jump Crypto, Pantera Capital, and billionaire Mark Cuban.
According to on-chain analytics platform DeFiLlama, Injective’s network has facilitated over 1 billion transactions, with its total value locked (TVL) currently at $39.48 million and 24-hour trading volume reaching $4.18 million. Despite market fluctuations, its native token INJ remains a key player in the DeFi space, currently trading at $13.76, though down 12% in a week and 63% over the past year.
Deutsche Telekom’s involvement with Injective is part of its broader strategy to become a major player in blockchain infrastructure. The company, which boasts over 252 million mobile customers, 25 million fixed-network lines, and 22 million broadband connections across more than 50 countries, has been steadily increasing its exposure to Web3 and decentralized technologies.
In November 2023, Deutsche Telekom MMS became a validator for Aleph Zero, a privacy-focused Layer-1 blockchain, reinforcing its commitment to blockchain security and enterprise-grade validation services. By June 2023, the company was already securing over €60 million worth of digital assets across major blockchain networks, including Ethereum, Chainlink, Celo, Flow, Polkadot, Polygon, and Energy Web.
Dirk Röder, Head of Web3 Infrastructure and Solutions at Deutsche Telekom MMS, hinted at more blockchain initiatives in the pipeline. “Deutsche Telekom is actively expanding its Web3 strategy and exploring new partnerships and integrations across the blockchain space,” Röder stated in late 2023.
Deutsche Telekom’s deeper engagement with Injective aligns with a broader trend of global institutions recognizing blockchain’s potential beyond speculative assets. Financial firms, banks, and telecom giants are now actively integrating decentralized networks to enhance their security, efficiency, and transparency in handling digital assets.
By securing an institutional-grade validator in Deutsche Telekom, Injective is not only strengthening its network but also paving the way for greater enterprise adoption of Web3-powered financial services.
